MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-07 |
2024-03 |
-0.14 |
N/A |
N/A |
N/A |
2024-03-12 |
2023-12 |
-0.1 |
-0.05 |
0.05 |
50.00% |
2023-11-08 |
2023-09 |
-0.1 |
-0.11 |
-0.01 |
-10.00% |
2023-11-08 |
2023-09 |
-0.1 |
N/A |
N/A |
N/A |
2023-08-09 |
2023-06 |
-0.1 |
-0.1 |
N/A |
N/A |
2023-08-09 |
2023-06 |
-0.1 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-10-04 |
Stephens & Co. |
Upgrade |
Overweight |
Overweight |
2023-03-27 |
Stephens & Co. |
Upgrade |
|
Overweight |
2022-08-14 |
BTIG |
Upgrade |
|
Buy |
2021-08-23 |
BTIG |
Upgrade |
|
Buy |
2021-08-23 |
Stifel |
Upgrade |
|
Buy |
2021-08-23 |
Cowen & Co. |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2022-10-02 |
CASDIN PARTNERS MASTER FUND, L.P. |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Sale |
2023-12-04 |
DOERFLER DOUGLAS A. |
Chief Executive Officer |
333.20K |
Sale |
2023-03-28 |
DOUGLAS RICHARD H |
Director |
100.00K |
Purchase |
2021-11-15 |
HOLTZ RONALD E. |
Officer |
125.25K |
Sale |
2024-03-25 |
JOHNSTON JOHN JOSEPH |
Director |
120.58K |
Sale |
2021-11-15 |
MASOUD MAHER J.D. |
General Counsel |
0.00 |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Blackrock Inc. |
6.92M |
31.76M |
6.68% |
2023-06-29 |
Vitruvian Partners, LLP |
5.04M |
23.15M |
4.87% |
2023-06-29 |
Vanguard Group Inc |
4.97M |
22.82M |
4.80% |
2023-06-29 |
Casdin Capital, LLC |
4.72M |
21.64M |
4.55% |
2023-06-29 |
Stonepine Capital Management, LLC |
3.97M |
18.21M |
3.83% |
2023-06-29 |
ArrowMark Colorado Holdings LLC |
2.58M |
11.83M |
2.49% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
2.82M |
12.94M |
2.72% |
2023-08-30 |
iShares Russell 2000 ETF |
2.01M |
7.35M |
1.94% |
2023-07-30 |
American Century Small Cap Growth Fund |
1.51M |
6.77M |
1.46% |
2023-06-29 |
Meridian Small Cap Growth Fund |
1.30M |
5.95M |
1.25% |
2023-05-30 |
MFS New Discovery Fund |
1.27M |
5.19M |
1.23% |
2023-06-29 |
Vanguard Extended Market Index Fund |
1.28M |
5.86M |
1.23% |